Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)
21 Sep 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|48||2016||Chairman of the Board|
|56||2016||President, Executive Director|
|44||2016||Chief Financial Officer, Vice President, Executive Director|
|47||2016||Vice President, Executive Director|
|37||2016||Vice President, Secretary of the Board|
- BRIEF-Shanghai Pharmaceuticals Says Q1 Net Profit Up 2.1 Percent Y/Y
- BRIEF-Shanghai Pharmaceuticals Says Q1 Net Profit Attributable RMB1.02 Billion
- Generics group Alvogen puts Eastern European ops up for sale -sources
- BRIEF-Shanghai Pharmaceuticals Holding to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares
- BRIEF-Shanghai Pharmaceuticals Says Co To Buy 100% Stake In New Century Pharmaceutical, Yide Pharmacy